全文获取类型
收费全文 | 8291篇 |
免费 | 466篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 90篇 |
儿科学 | 305篇 |
妇产科学 | 270篇 |
基础医学 | 779篇 |
口腔科学 | 285篇 |
临床医学 | 794篇 |
内科学 | 1914篇 |
皮肤病学 | 244篇 |
神经病学 | 627篇 |
特种医学 | 306篇 |
外科学 | 1459篇 |
综合类 | 106篇 |
一般理论 | 7篇 |
预防医学 | 462篇 |
眼科学 | 199篇 |
药学 | 463篇 |
中国医学 | 36篇 |
肿瘤学 | 452篇 |
出版年
2024年 | 12篇 |
2023年 | 107篇 |
2022年 | 183篇 |
2021年 | 395篇 |
2020年 | 257篇 |
2019年 | 353篇 |
2018年 | 340篇 |
2017年 | 252篇 |
2016年 | 266篇 |
2015年 | 270篇 |
2014年 | 386篇 |
2013年 | 409篇 |
2012年 | 717篇 |
2011年 | 700篇 |
2010年 | 406篇 |
2009年 | 349篇 |
2008年 | 503篇 |
2007年 | 518篇 |
2006年 | 420篇 |
2005年 | 382篇 |
2004年 | 325篇 |
2003年 | 300篇 |
2002年 | 253篇 |
2001年 | 81篇 |
2000年 | 67篇 |
1999年 | 65篇 |
1998年 | 37篇 |
1997年 | 41篇 |
1996年 | 35篇 |
1995年 | 24篇 |
1994年 | 18篇 |
1993年 | 27篇 |
1992年 | 21篇 |
1991年 | 28篇 |
1990年 | 28篇 |
1989年 | 14篇 |
1988年 | 23篇 |
1987年 | 19篇 |
1986年 | 16篇 |
1985年 | 26篇 |
1984年 | 24篇 |
1983年 | 15篇 |
1982年 | 10篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1974年 | 7篇 |
1973年 | 5篇 |
排序方式: 共有8798条查询结果,搜索用时 15 毫秒
101.
Malvi Surti Mitesh Patel Mohd Adnan Afrasim Moin Syed Amir Ashraf Arif Jamal Siddiqui Mejdi Snoussi Sumukh Deshpande Mandadi Narsimha Reddy 《RSC advances》2020,10(62):37707
The outbreak of novel coronavirus, SARS-CoV-2, has infected more than 36 million people and caused approximately 1 million deaths around the globe as of 9 October 2020. The escalating outspread of the virus and rapid rise in the number of cases require the instantaneous development of effectual drugs and vaccines. Presently, there are no approved drugs or vaccine available to treat the infection. In such scenario, one of the propitious therapeutic approaches against viral infection is to explore enzyme inhibitors amidst natural compounds, utilizing computational approaches aiming to get products with negligible side effects. In the present study, the inhibitory prospects of ilimaquinone (marine sponge metabolite) were assessed in comparison with hydroxychloroquine, azithromycin, favipiravir, ivermectin and remdesivir at the active binding pockets of nine different vital SARS-CoV-2 target proteins (spike receptor binding domain, RNA-dependent RNA polymerase, Nsp10, Nsp13, Nsp14, Nsp15, Nsp16, main protease, and papain-like-protease), employing an in silico molecular interaction based approach. In addition, molecular dynamics (MD) simulations of the SARS-CoV-2 papain-like protease (PLpro)–ilimaquinone complex were also carried out to calculate various structural parameters including root mean square fluctuation (RMSF), root mean square deviation (RMSD), radius of gyration (Rg) and hydrogen bond interactions. PLpro is a promising drug target, due to its imperative role in viral replication and additional function of stripping ubiquitin and interferon-stimulated gene 15 (ISG15) from host-cell proteins. In light of the possible inhibition of all vital SARS-CoV-2 target proteins, our study has emphasized the importance to study in depth ilimaquinone actions in vivo.Inhibitory potential of ilimaquinone (marine sponge metabolite) against nine essential SARS-CoV-2 target proteins, employing a molecular interaction and dynamics simulation approach. 相似文献
102.
Afrasim Moin N. K. Famna Roohi Syed Mohd Danish Rizvi Syed Amir Ashraf Arif Jamal Siddiqui Mitesh Patel S. M. Ahmed D. V. Gowda Mohd Adnan 《RSC advances》2020,10(57):34869
Three drugs namely caffeine, paracetamol, and aceclofenac are commonly used for treating various acute and chronic pain related ailments. These 3 drugs have varied solubility profiles, and formulating them into a single tablet did not have the desired dissolution profile for drug absorption. The objective of the present research was to tailor the drug release profile by altering drug solubility. This was achieved by loading the drug into nanosponges. Here, three-dimensional colloidal nanosponges were prepared using β-cyclodextrin with dimethyl carbonate as a cross-linker using the hot-melt compression method. The prepared nanosponges were characterized by FTIR, 1H NMR spectroscopy, DSC, XRPD studies and SEM. The FTIR and DSC results obtained indicated polymer-drug compatibility. The 1H NMR spectroscopy results obtained indicated the drug entrapment within nanosponges with the formation of the inclusion complex. XRPD studies showed that the loaded drug had changed crystalline properties altering drug solubility. SEM photographs revealed the porous and spongy texture on the surface of the nanosponge. Box–Behnken experimental design was adopted for the optimization of nanosponge synthesis. Among the synthesized nanosponges containing paracetamol, aceclofenac and caffeine, batch F3–P31, F3–A31 and F3–C31 were considered optimized. Their particle size was 185, 181 and 199 nm with an entrapment efficiency of 81.53, 84.96, and 89.28% respectively. These optimized nanosponges were directly compressed into tablets and were studied for both pre and post-compression properties including in vitro drug release. The prepared tablet showed desired drug dissolution properties compared to the pure drug. The above outcomes indicated the applicability of nanosponges in modulating the drug release with varied solubility for combination therapy.Polymeric nanosponges as potential carriers for successful combination therapy of poorly soluble drugs (paracetamol, aceclofenac, caffeine). 相似文献
103.
Niloofar Rahmani Shahin Amani Amir Bagheri Garmarudi Mohammadreza Khanmohammadi 《RSC advances》2020,10(58):35366
Correction for ‘The β-cyclodextrin-modified nanosized ZSM-5 zeolite as a carrier for curcumin’ by Shahin Amani et al., RSC Adv., 2019, 9, 32348–32356, DOI: 10.1039/C9RA04739E.The authors regret that the names of the authors were listed incorrectly in the original article. The corrected author list is as shown above.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers. 相似文献
104.
105.
106.
107.
108.
109.
Amir A. Rahnemai‐Azar Brian F. Gilchrist Liise K. Kayler 《Clinical transplantation》2015,29(5):403-408
Urologic complications are the most frequent technical adverse events following kidney transplantation (KTX). We evaluated traditional and novel potential risk factors for urologic complications following KTX. Consecutive KTX recipients between December 1, 2006 and December 31, 2010 with at least six‐month follow‐up (n = 635) were evaluated for overall urologic complications accounting for donor, recipient, and transplant characteristics using univariate and multivariate logistic regression. Urologic complications occurred in 29 cases (4.6%) at a median of 40 d (range 1–999) post‐transplantation and included 17 ureteral strictures (2.6%), five (0.8%) ureteral obstructions due to donor‐derived stones or intraluminal thrombus, and seven urine leaks (1.1%). All except two complications occurred within the first year of transplantation. Risk factors for urologic complications on univariate analysis were dual KTX (p = 0.04) and renal artery multiplicity (p = 0.02). On multivariate analysis, only renal artery multiplicity remained significant (aHR 2.4, 95% confidence interval 1.1, 5.1, p = 0.02). Donation after cardiac death, non‐mandatory national share kidneys, donor peak serum creatinine > 1.5 mg/dL or creatinine phosphokinase > 1000 IU/L, and donor down time were not associated with urologic complications. Our data suggest that donor artery multiplicity is an independent risk factor for urologic complications following KTX. 相似文献
110.